Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR–JAK2 fusion transcript

European Journal of Haematology

Volumn 97, Issue 4, 2016, Pages 399-402

  Duployez, Nicolas ^a,b   Nibourel, Olivier ^a,b   Ducourneau, Benoît ^a   Grardel, Nathalie ^a   Boyer, Thomas ^a,b   Bories, Claire ^a   Darre, Stéphane ^c   Coiteux, Valérie ^a   Berthon, Céline ^a,b   Preudhomme, Claude ^a,b   Roche Lestienne, Catherine ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c Claude Huriez Hospital ^*  (France)

Author keywords

acute leukemia; BCR JAK2; cytogenetics; IKZF1; myeloproliferative neoplasms; SNP array

Indexed keywords

ASPARAGINASE; BREAKPOINT CLUSTER REGION PROTEIN; BUSULFAN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLOPHOSPHAMIDE; DAUNORUBICIN; EBF1 PROTEIN; FLUDARABINE; HEMOGLOBIN; HYDROXYUREA; IKZF1 PROTEIN; JANUS KINASE 2; PREDNISONE; PROTEIN; RUXOLITINIB; THIOTEPA; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ARTICLE; BLAST CELL; BLAST CELL CRISIS; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME 22; CHROMOSOME 8; COMBINATION CHEMOTHERAPY; CYTOGENETICS; DISEASE COURSE; EOSINOPHIL COUNT; EXON; FATIGUE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; LEUKOCYTE COUNT; LYMPHOCYTE TRANSFORMATION; MALE; METAPHASE; MIDDLE AGED; MYELOABLATIVE CONDITIONING; MYELOPROLIFERATIVE NEOPLASM; NEUTROPHIL COUNT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRISOMY; TRISOMY 8; WEAKNESS;

EID: 84986593894     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12752     Document Type: Article

References (5)

1. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470–80.
2. Chamseddine AN, Etancelin P, Penther D, et al. Transformation of an unclassified myeloproliferative neoplasm with a rare BCR-JAK2 fusion transcript resulting from the translocation (9;22)(p24;q11). Case Rep Hematol 2015;2015:252537.
3. Tsai P-C, Huang S-W, Tsai HL, Ma CJ, Hou MF, Yang IP, Wang YS, Juo SH, Wang JY. The association between DNA copy number aberrations at chromosome 5q22 and gastric cancer. PLoS One 2014;9:e106624.
4. Saharinen P, Takaluoma K, Silvennoinen O. Regulation of the JAK2 tyrosine kinase by its pseudokinase domain. Mol Cell Biol 2000;20:3387–95.
5. Cuesta-Domínguez Á, Ortega M, Ormazábal C, et al. Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase. PLoS One 2012;7:e32451.